...Good afternoon, everybody. The Vivoryon management welcomes you to the virtual Kidney Disease KOL Event, where we will discuss novel pathways to address the unmet medical need in diabetic kidney disease and often kidney diseases. I would like to remind you that during this conference we will present and discuss certain forward-looking statements concerning the development of Vivoryon core platform, the progress of its current research and development and the initiation of additional programs as well as results of operations, cash needs, financial conditions, liquidity prospects, future transactions as strategies. Should actual results differ from the company's assumptions, ensuing actions may differ from those anticipated. You are therefore cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date [year]. Next slide, please. With us today a speakers, Tobias Huber, who is the Chairman and Director of the third clinic Department of Medicine...
